Horizon Discovery

About Horizon Discovery

Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.

Explore similar firms in the Pharmaceuticals

Email Format

{first_name}.{last_name}@horizondiscovery.com — 100.0%

sarah.smith@horizondiscovery.com

Key Employees

Contact details of 8 Horizon Discovery executives

Jon Nunez

Vice President , Finance
  • Work email

    j*******z@horizondiscovery.com

Richard Vellacott

Chief Financial Officer

Jayesh Pankhania

Chief Financial Officer

Alberto Bardelli

Founder

Andrew Cohen

Head of Global Marketing

Chris Lowe

Head of Research Operations

Chris Torrance

Founder

Darrin Disley

Founder

Other Employees

Contact details of 10 Horizon Discovery other employees

Kevin Koker

Customer Service Manager
  • Work email

    k*********r@horizondiscovery.com

Jon Aviles

General Manager
  • Work email

    j********s@horizondiscovery.com

Natalie Cowan

Business Development Manager
  • Work email

    n***********n@horizondiscovery.com

Jeffrey Dale

Business Development Manager, Midwest (South), Products and Services (including In Vivo)
  • Work email

    j**********e@horizondiscovery.com

Abhay Joshi

Business Development Manager
  • Work email

    a*********i@horizondiscovery.com

Hadas Raveh-Amit

Senior Scientist
  • Work email

    h*************t@horizondiscovery.com

Andrea Frapporti

Job not specified
  • Work email

    a**************i@horizondiscovery.com

U003eandrea Frapporti

Job not specified
  • Work email

    u*******************i@horizondiscovery.com

Emily Anderson

Senior Scientist

Jamie Freeman

Corporate Innovation Partner

General Emails

General company emails, e.g. customer support lines

    info@horizondiscovery.com

    General Inquiries

    sales@horizondiscovery.com

    Sales Department

    legal@horizondiscovery.com

    Legal Department

    j.moore@horizondiscovery.com

    Unclassified inbox

    darrin.disley@horizondiscovery.com

    Unclassified inbox

    noreply@horizondiscovery.com

    Unclassified inbox

Similar Companies like Horizon Discovery

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Legal Name: AbbVie Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Legal Name: Pfizer Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital

HQ: Rahway, New Jersey, United States

Merck

merck.com

Merck is a biopharmaceutical company that offers medicines a...

HQ: Rahway, New Jersey, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Legal Name: Merck & Co., Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Equity

Last Investment Activity: Mar 28, 2024

Founded Date: 1891

Number of Exits: 9

Company Type: For Profit

Stock Symbol: NYSE:MRK

Operating Status: Active

Company Info

Last updated: 29/07/2025

+44 (0) 1223 976 000

Cambridge, Cambridgeshire, United Kingdom

Horizon Discovery General Information

Specialization: Pharmaceuticals, Biotechnology, Health Diagnostics
Legal Name: Horizon Discovery Ltd.,
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Founded Date: Jun 2007
Company Type: For Profit
Stock Symbol: LSE:HZD
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +44 (0) 1223 976 000
Last Investment Activity: Feb 10, 2022
Investments Activity: Feb 10, 2022 May 13, 2021 Dec 1, 2020

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.